drugset / Trial / NCT01425398
A Trial to Evaluate the Effect of Rosuvastatin on Inflammation in Patients Undergoing Isolated Cardiac Valve Surgery
Phase 3
Completed
170 enrolled
McGill University Health Centre/Research Institute of the McGill University Health Centre
RandomizedParallel-groupQuadruple-blindTreatment
Summary
High-dose statin therapy around the time of surgery, decreases inflammation in patients undergoing cardiac valve surgery, and thereby improves clinical outcomes.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 40 mg | Oral |